Reevaluation of the 22-1-1 antibody and its putative antigen, EBAG9/RCAS1, as a tumor marker

BACKGROUND: Tumor-associated antigens are appreciated as diagnostic markers, but they have also prompted tremendous efforts to develop tumor-specific immunotherapy. A previously cloned tumor-associated antigen, EBAG9, was initially defined by reactivity with the monoclonal antibody 22-1-1. Functiona...

Descripción completa

Detalles Bibliográficos
Autores principales: Reimer, Tatiana A, Anagnostopoulos, Ioannis, Erdmann, Bettina, Lehmann, Insa, Stein, Harald, Daniel, Peter, Dörken, Bernd, Rehm, Armin
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1164403/
https://www.ncbi.nlm.nih.gov/pubmed/15904507
http://dx.doi.org/10.1186/1471-2407-5-47

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1164403/
https://www.ncbi.nlm.nih.gov/pubmed/15904507
http://dx.doi.org/10.1186/1471-2407-5-47

Ejemplares similares